HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Karen Bräutigam Selected Research
Karen Bräutigam Research Topics
Disease
9
Neoplasms (Cancer)
11/2018 - 01/2007
6
Ovarian Neoplasms (Ovarian Cancer)
05/2015 - 01/2007
3
Triple Negative Breast Neoplasms
10/2021 - 06/2016
2
Breast Neoplasms (Breast Cancer)
08/2016 - 06/2016
2
Carcinoma (Carcinomatosis)
02/2013 - 01/2007
2
Papillary Carcinoma
02/2013 - 01/2007
1
Carcinogenesis
10/2021
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2020
1
Necrosis
08/2016
1
Melanoma (Melanoma, Malignant)
05/2016
1
Skin Neoplasms (Skin Cancer)
05/2016
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2016
1
Endometriosis
09/2013
1
Arthritis (Polyarthritis)
04/2010
1
Asthma (Bronchial Asthma)
02/2008
1
Atopic Dermatitis (Atopic Eczema)
02/2008
1
Crohn Disease (Crohn's Disease)
02/2008
1
Autoimmune Diseases (Autoimmune Disease)
01/2005
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2003
Drug/Important Bio-Agent (IBA)
4
Proteins (Proteins, Gene)
FDA Link
05/2015 - 04/2003
3
Biomarkers (Surrogate Marker)
IBA
07/2020 - 01/2007
3
Cisplatin (Platino)
FDA Link
Generic
05/2015 - 08/2009
2
Mitogen-Activated Protein Kinase 3
IBA
10/2021 - 08/2009
2
Paraffin
IBA
07/2020 - 02/2013
2
Indicators and Reagents (Reagents)
IBA
11/2018 - 05/2016
2
Antibodies
IBA
08/2016 - 02/2013
2
ErbB Receptors (EGF Receptor)
IBA
08/2016 - 05/2016
2
Oligonucleotides
IBA
02/2013 - 01/2007
2
Gemcitabine
FDA Link
05/2011 - 08/2009
2
Pemetrexed (MTA)
FDA Link
05/2011 - 08/2009
2
Docetaxel (Taxotere)
FDA Link
05/2011 - 08/2009
2
Pharmaceutical Preparations
IBA
05/2011 - 08/2009
2
Etoposide (VP 16)
FDA Link
Generic
05/2011 - 08/2009
2
Paclitaxel (Taxol)
FDA Link
Generic
05/2011 - 08/2009
1
Adenosine Triphosphatases (ATPase)
IBA
07/2020
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
07/2020
1
Formaldehyde (Formol)
FDA Link
07/2020
1
Coloring Agents (Dyes)
IBA
11/2018
1
Photosensitizing Agents (Photosensitizers)
IBA
08/2016
1
chondroitin sulfate proteoglycan 4
IBA
08/2016
1
Epithelial Cell Adhesion Molecule
IBA
08/2016
1
human ERBB2 protein
IBA
08/2016
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
08/2016
1
phthalocyanine
IBA
08/2016
1
Estrogen Receptors
IBA
08/2016
1
Progesterone Receptors (Progesterone Receptor)
IBA
08/2016
1
eribulin
FDA Link
06/2016
1
Messenger RNA (mRNA)
IBA
05/2015
1
Fatty Acids (Saturated Fatty Acids)
IBA
05/2015
1
Platinum
IBA
05/2015
1
Fatty Acid Synthases (Fatty Acid Synthase)
IBA
05/2015
1
Heme (Haem)
IBA
09/2013
1
Hemopexin
IBA
09/2013
1
Iron
IBA
09/2013
1
Claudin-3
IBA
02/2013
1
Mesothelin
IBA
02/2013
1
RNA (Ribonucleic Acid)
IBA
02/2013
1
Hypoglycemic Agents (Hypoglycemics)
IBA
05/2011
1
Ligands
IBA
05/2011
1
Cytostatic Agents
IBA
05/2011
1
Disintegrins
IBA
04/2010
1
Thrombospondins
IBA
04/2010
1
Metalloproteases (Metalloproteinases)
IBA
04/2010
1
enzastaurin
IBA
08/2009
1
Folic Acid (Vitamin M)
FDA Link
Generic
08/2009
1
Leucine (L-Leucine)
FDA Link
02/2008
1
Acetylmuramyl-Alanyl-Isoglutamine
IBA
02/2008
1
Matrix Metalloproteinase 7 (Matrilysin)
IBA
01/2007
1
Secretory Leukocyte Peptidase Inhibitor
IBA
01/2007
1
Kallikreins (Kallikrein)
IBA
01/2007
1
Osteopontin
IBA
01/2007
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2005
Therapy/Procedure
4
Therapeutics
08/2016 - 01/2005
3
Drug Therapy (Chemotherapy)
10/2021 - 08/2009
2
Precision Medicine
01/2017 - 05/2016
1
Hysterectomy
07/2020
1
Radiotherapy
07/2020
1
Investigational Therapies (Experimental Therapy)
05/2011
1
Adjuvant Chemotherapy
01/2011